ArticleJournal of experimental & clinical cancer research : CR2025

Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer.

Bo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.